• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Vasculitis Center

Show Search
Hide Search
  • About Our Center
    • Appointments and Directions
    • Meet Our Team
    • Support Our Center
  • What is Vasculitis?
    • Types of Vasculitis
    • Causes of Vasculitis
    • Symptoms of Vasculitis
    • Diagnosing Vasculitis
  • Vasculitis Treatments
    • Prednisone
    • Avacopan (Tavneos®)
    • Apremilast (Otezla®)
    • Azathioprine
    • Colchicine
    • Cyclophosphamide (Cytoxan)
    • Dapsone
    • Supplemental Immunoglobulin (IVIG/SCIG)
    • Leflunomide
    • Mepolizumab (Nucala®)
    • Methotrexate (MTX)
    • Mycophenolate
    • Rituximab
    • Sarilumab (Kevzara®)
    • TNF Inhibitors
    • Tocilizumab (Actemra®)
  • Vasculitis Research
  • Resources
Home / Vasculitis Treatments / Cyclophosphamide (Cytoxan)

Cyclophosphamide (Cytoxan)

What is cyclophosphamide?

Cyclophosphamide is a potent immunosuppressive drug that is used in the treatment of severe forms of vasculitis, as well as other autoimmune diseases of other sorts with severe manifestations. We use Cyclophosphamide is used in higher doses as a chemotherapeutic drug to treat some forms of cancer.

How does cyclophosphamide work?

Cyclophosphamide has a toxic effect on immune cells, and therefore suppresses the immune system to a significant degree.

How is cyclophosphamide given?

Cyclophosphamide can be used as a pill taken by mouth every day, or as an infusion given every few weeks. The specific dosing used depends on several factors, including a patient’s age and weight. When oral cyclophosphamide is used, it is important for patients to take cyclophosphamide early in the morning with a large glass of water, and to stay well hydrated during the day.

Side effects:

Cyclophosphamide is a strong immunosuppressant and puts patients at risk of infections. It is extremely important that patients report any signs of infection while using cyclophosphamide. We often need to prescribe an antibiotic (Bactrim) to prevent fungal pneumonia in patients taking cyclophosphamide. Patients need to have frequent lab testing to monitor blood counts, kidney function, and urine for the presence of blood while taking cyclophosphamide. Because cyclophosphamide can cause injury to the bladder, it is important for patients to drink plenty of fluids while using cyclophosphamide.

All immunosuppressants require regular monitoring in the form of blood tests, in-person assessments, and vigilance for signs of infection.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Vasculitis website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

  • Prednisone
  • Avacopan (Tavneos®)
  • Apremilast (Otezla®)
  • Azathioprine
  • Colchicine
  • Cyclophosphamide (Cytoxan)
  • Dapsone
  • Supplemental Immunoglobulin (IVIG/SCIG)
  • Leflunomide
  • Mepolizumab (Nucala®)
  • Methotrexate (MTX)
  • Mycophenolate
  • Rituximab
  • Sarilumab (Kevzara®)
  • TNF Inhibitors
  • Tocilizumab (Actemra®)

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2025 Johns Hopkins Vasculitis Center
Patient Privacy